OmniSeq Receives CAP Accreditation and Publishes Analytical Validation Paper
Nov 09, 2017 13:02 pm UTC| Business
BUFFALO, N.Y., Nov. 09, 2017 -- OmniSeq, Inc., a molecular diagnostics subsidiary of Roswell Park Cancer Institute, announced today that it received accreditation by the College of American Pathologists (CAP), meeting...
Motorcar Parts of America Reports Fiscal 2018 Second Quarter Results
Nov 09, 2017 13:02 pm UTC| Business
LOS ANGELES, Nov. 09, 2017 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today reported record sales for its fiscal 2018 second quarter and six-month period -- despite widely reported industry softness and associated...
ABM Saves Connellsville Area School District $26.4 Million in Operating Costs
Nov 09, 2017 13:02 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- ABM (NYSE:ABM), a leading provider of facility solutions, has initiated an Energy Performance Contracting program for Connellsville Area School District in Fayette County, Pennsylvania. ABM’s...
Nov 09, 2017 13:02 pm UTC| Business
LOS ANGELES, CA, Nov. 09, 2017 -- Oaktree Strategic Income Corporation (NASDAQ:OCSI) (“Oaktree Strategic Income”) today announced that it will report its financial results for the fourth fiscal quarter and full year...
Nov 09, 2017 13:01 pm UTC| Business
LOS ANGELES, CA, Nov. 09, 2017 -- Oaktree Specialty Lending Corporation (NASDAQ:OCSL) (“Oaktree Specialty Lending”) today announced that it will report its financial results for the fourth fiscal quarter and full year...
Nov 09, 2017 13:01 pm UTC| Business
SAN DIEGO, CA, Nov. 09, 2017 -- Global Payout, Inc. (OTCPink: GOHE) (“Global”) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”) continues to make significant...
Albireo to Present at the Jefferies 2017 London Healthcare Conference
Nov 09, 2017 13:01 pm UTC| Business
BOSTON, Nov. 09, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update